Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
CACNA1C encodes an alpha-1 subunit of a voltage-dependent calcium channel. Additionally we are shipping Calcium Channel, Voltage-Dependent, L Type, alpha 1C Subunit Proteins (9) and Calcium Channel, Voltage-Dependent, L Type, alpha 1C Subunit Kits (3) and many more products for this protein.
Showing 10 out of 186 products:
Hamster Monoclonal CACNA1C Primary Antibody for ICC, IF - ABIN361759
Krey, Moussay, Thiel, Ruemenapf: Role of the low-density lipoprotein receptor in entry of bovine viral diarrhea virus. in Journal of virology 2006
Show all 3 references for ABIN361759
Human Polyclonal CACNA1C Primary Antibody for EIA, IP - ABIN1105621
Lemke, Welling, Christel, Blaich, Bernhard, Lenhardt, Hofmann, Moosmang: Unchanged beta-adrenergic stimulation of cardiac L-type calcium channels in Ca v 1.2 phosphorylation site S1928A mutant mice. in The Journal of biological chemistry 2008
Human Polyclonal CACNA1C Primary Antibody for BP, IP - ABIN452092
Eden, Meder, Völkers, Poomvanicha, Domes, Branchereau, Marck, Will, Bernt, Rangrez, Busch, Hrabě de Angelis, Heymes, Rottbauer, Most, Hofmann, Frey: Myoscape controls cardiac calcium cycling and contractility via regulation of L-type calcium channel surface expression. in Nature communications 2016
Human Monoclonal CACNA1C Primary Antibody for ICC, IF - ABIN447361
Carnevale, Vecchione, Mascio, Esposito, Cifelli, Martinello, Landolfi, Selvetella, Grieco, Damato, Franco, Haase, Maffei, Ciraolo, Fucile, Frati, Mazzoni, Hirsch, Lembo: PI3Kγ inhibition reduces blood pressure by a vasorelaxant Akt/L-type calcium channel mechanism. in Cardiovascular research 2011
Human Polyclonal CACNA1C Primary Antibody for IHC, WB - ABIN1742110
Kreuzberg, Theissen, Schicha, Schröder, Mehlhorn, de Vivie, Bokník, Neumann, Grohé, Herzig: Single-channel activity and expression of atrial L-type Ca(2+) channels in patients with latent hyperthyroidism. in American journal of physiology. Heart and circulatory physiology 2000
Human Polyclonal CACNA1C Primary Antibody for EIA, WB - ABIN375180
Saud, Minobe, Wang, Han, Horiuchi, Hao, Kameyama: Calpastatin binds to a calmodulin-binding site of cardiac Cav1.2 Ca2+ channels. in Biochemical and biophysical research communications 2007
Competitive and non-competitive regulation of calcium-dependent inactivation in CaV1.2 L-type Ca2 (show CA2 Antibodies)+ channels by calmodulin (show Calm2 Antibodies) and Ca2 (show CA2 Antibodies)+-binding protein 1.
a direct physical interaction between the N terminus (NT) and C terminus (CT) of the main subunit of the L-type Ca(2 (show CA2 Antibodies)+) channel CaV1.2, alpha1C, is reported.
These results reveal a new dimension of regulation of Ca(V)1.2 channels through phosphorylation of the Hook domains of their beta subunits.
These findings suggest that N-glycosylation contributes to the surface expression and voltage-dependent gating of Cav1.2.
Data show that cardiac L-type calcium (CaV1.2) channels form clusters that undergo dynamic, reciprocal, allosteric interactions.
these findings provide evidence for a new role of Homer1 (show HOMER1 Antibodies) supporting the regulation of Cav1.2 channels by STIM1 (show STIM1 Antibodies).
structural flexibility of CaV1.2 and CaV2.2 (show CACNA1B Antibodies) I-II proximal linker
These results suggest a complex antagonistic interplay between G(q)-activated PKC and Gbetagamma in regulation of L-VDCC, in which multiple cytosolic segments of alpha(1C) are involved.
There were substantial transmural gradients in Cav1.2, KChIP2 (show KCNIP2 Antibodies), ERG (show KCNH2 Antibodies), KvLQT1 (show KCNQ1 Antibodies), Kir2.1 (show KCNJ2 Antibodies), NCX1 (show SLC8A1 Antibodies), SERCA2a (show ATP2A2 Antibodies) and RyR2 (show RYR2 Antibodies) at the mRNA and, in some cases, protein level-in every case the mRNA or protein was more abundant in the epicardium than the endocardium.
Ca v1.2 binding site for PP2A and PP2B
Swapping the I-II intracellular linker between L-type CaV1.2 and R-type CaV2.3 (show CACNA1E Antibodies) high-voltage gated calcium channels exchanges activation attributes.
the association of rs1006737 with gray matter volume in a sample of 278 healthy Han Chinese, was examined.
the function of purified human Cav1.2 in proteoliposomes, was investigated.
The linking variation in the CACNA1C gene is a neurochemical marker of neuroaxonal plasticity in those with bipolar disorder.
Copy number increase of CACNA1C are associated with esophageal squamous cell carcinoma.
CACNA1C modulates the cellular rhythm amplitude response to lithium, providing a specific link between LTCCs and circadian rhythms in the context of Bipolar disorder and lithium
Findings indicate that CACNA1C-related differences in amygdala structure and function are present by adolescence.
The associations of CACNA1C rs10774035 with outcome in schizophrenia-spectrum and non-association with outcome in bipolar disorders
Single nucleotide polymorphism in an intron of the CACNA1C gene conveyed an increased risk for developing Bipolar disorder.
CACNA1C risk variant affects facial emotion recognition in healthy individuals.
This integrative genomic study confirmed the role of RUNX2 (show RUNX2 Antibodies) as a potential driver of AS and identified a new AS susceptibility gene, CACNA1C, belonging to the calcium signaling pathway.
K(ATP) channel gain-of-function leads to increased myocardial L-type Ca(2 (show CA2 Antibodies)+) current and contractility in Cantu (show ABCC9 Antibodies) syndrome.
This study demonstrate a role of Cav1.2 in regulating survival of young hippocampal neurons in living mice by studying both forebrain-Cav1.2 cKO mice.
Results provide evidence that decreased Cacna1c expression has a protective role in the modulation of age-related cognitive declines, and support an interaction between Cacna1c, sex and memory impairment
Both the extracellular PFXYD motif and the transmembrane domain of PLM (show FXYD1 Antibodies) but not the cytoplasmic tail were necessary for regulation of peak L-type Ca(2 (show CA2 Antibodies)+) current amplitude.
Treatment of MSC (show MSC Antibodies) with BMP4 (show BMP4 Antibodies) caused a significant increase in expression of Cav1.2, a delay in expression of Cav1.1 (show CACNA1S Antibodies), and a reduction in the duration of calcium transients when extracellular calcium was removed
data suggest that miR (show MLXIP Antibodies)-103 inhibits osteoblast proliferation mainly through suppression of Cav1.2 expression under simulated microgravity condition
The down-regulation of Cav1.2 expression and the inhibition of LTCCs caused by mechanical unloading in osteoblasts are partially due to miR (show MLXIP Antibodies)-103 up-regulation.
Ammonium-induced deregulation of astroglial Ca(2 (show CA2 Antibodies)+) signalling, is, in part, associated with upregulation of Cav1.2 L-type calcium channels
Methamphetamine alters DNA methylation (show HELLS Antibodies), expression, and protein abundance of CACNA1C.
demonstrate for the first time that both Cav1.2 and Cav1.3 (show CACNA1D Antibodies) are necessary for neuronal survival but are differentially required for the biophysical properties of neurons
These results suggest that structural rearrangements of CaV1.2 generated through the binding of BayK8644 or FPL64176, by altering the channel activity, could affect depolarization-evoked catecholamine secretion prior to cation transport.
CaV3.1 (show CACNA1G Antibodies) structural analysis and comparison to CaV1.2 channel
These results suggest that PKA and phosphatase(s) attached on or near the Ca(V)1.2 channel regulate the basal channel activity, presumably through modulation of the dynamic CaM (show CALM Antibodies) interaction with the channel.
CaM (show CALM Antibodies) may tether to the channel with its single lobe, leading to multiple CaM (show CALM Antibodies) molecule binding to increase the grade of Ca(2 (show CA2 Antibodies)+)-dependent regulation of Cav1.2
This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits.
, island beat
, voltage-dependent L-type calcium channel subunit alpha-1C
, L-type Ca channel alpha 1 subunit
, L-type calcium channel CaV1.2
, atrium L-type calcium channel
, calcium channel, voltage-dependent, L type, alpha 1C subunit
, voltage-dependent L-type calcium channel subunit alpha-1C-like
, calcium channel voltage-dependent L type Cav1.2, alpha 1c subunit
, CaCB receptor
, smooth muscle calcium channel blocker
, DHPR, alpha-1 subunit
, calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle
, calcium channel, cardic dihydropyridine-sensitive, alpha-1 subunit
, voltage-gated L-type calcium channel Cav1.2 alpha 1 subunit, splice variant 10*
, L-type Cav1.2
, brain class C
, calcium channel voltage-dependent alpha1c subunit
, neuronal voltage-gated calcium channel alpha 1C subunit
, skeletal muscle-specific calcium channel
, voltage-gated calcium channel subunit alpha Cav1.2
, L-type calcium channel alpha-1 subunit
, calcium channel, voltage-dependent, alpha 1C subunit
, voltage-gated calcium channel alpha 1C subunit
, L-type voltage-gated calcium channel alpha1C subunit ChCaChA1C
, L-type voltage-dependent calcium channel alpha-1 subunit
, cardiac L-type calcium channel
, Voltage-dependent L-type calcium channel subunit alpha-1C